Skip to main content

Quest Diagnostics Incorporated (0KSX.L)

London Stock Exchange Healthcare Medical - Equipment & ServicesView data quality →
55.0Fair

ValueMarkers Composite Index

Top 53%#21,014 of 44,707
Slightly Undervalued

16% below intrinsic value ($229)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-2.57
Low Risk
Altman
3.30
Safe
DCF Value
$229
Undervalued
ROIC
8.2%
Adequate
P/E
21.6
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Quest Diagnostics Incorporated (0KSX.L) — VMCI valuation read

0KSX.L screens at VMCI 55/100, a 5-point gap above the Healthcare sector median (50). For a mid-cap Quest Diagnostics Incorporated share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

0KSX.L has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 0KSX.L trades at 26.0x earnings, 44% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.0x leaves covenant headroom, which sets the rate-cycle exposure for Quest Diagnostics Incorporated.

0KSX.L fell 0.7% over the trailing 7 days, with a -18.8% read on a 30-day basis.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

CEO: James E. Davis55,000 employeesUSwww.questdiagnostics.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 0KSX.L’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.